c-myc Amplifications in primary breast carcinomas and their local recurrences
暂无分享,去创建一个
P. Schirmacher | B. Helmchen | S. Aulmann | H. Sinn | J. Rom | J Rom | S Aulmann | H P Sinn | P Schirmacher | N Adler | B Helmchen | N. Adler
[1] F. Vicini,et al. Does local recurrence affect the rate of distant metastases and survival in patients with early‐stage breast carcinoma treated with breast‐conserving therapy? , 2003, Cancer.
[2] C. Isaacs,et al. New prognostic factors for breast cancer recurrence. , 2001, Seminars in oncology.
[3] Peter Devilee,et al. Pathology and Genetics of Tumours of the Breast and Female Genital Organs , 2003 .
[4] C. Perou,et al. MYC Is Amplified in BRCA1-Associated Breast Cancers , 2004, Clinical Cancer Research.
[5] R. Jäger,et al. Overexpression of Bcl-2 inhibits alveolar cell apoptosis during involution and accelerates c-myc-induced tumorigenesis of the mammary gland in transgenic mice , 1997, Oncogene.
[6] L. Holmberg,et al. Time trends in the results of breast conservation in 4694 women. , 2001, European journal of cancer.
[7] R. Dickson,et al. c-Myc alters the DNA damage-induced G2/M arrest in human mammary epithelial cells , 2003, British Journal of Cancer.
[8] P. Lichter,et al. Detection of chromosomal aberrations by means of molecular cytogenetics: painting of chromosomes and chromosomal subregions and comparative genomic hybridization. , 1995, Methods in enzymology.
[9] S. Devries,et al. Genetic alterations in ERBB2-amplified breast carcinomas. , 1999, Clinical cancer research : an official journal of the American Association for Cancer Research.
[10] Takafumi Nishizaki,et al. Genetic alterations in primary breast cancers and their metastases: Direct comparison using modified comparative genomic hybridization , 1997, Genes, chromosomes & cancer.
[11] J. Coebergh,et al. Local recurrence after breast conservation therapy for early stage breast carcinoma , 1999 .
[12] J. Engel,et al. Determinants and prognoses of locoregional and distant progression in breast cancer. , 2003, International journal of radiation oncology, biology, physics.
[13] A. Legorreta,et al. Diagnosis, Clinical Staging, and Treatment of Breast Cancer: A Retrospective Multiyear Study of a Large Controlled Population , 2004, American journal of clinical oncology.
[14] S. Aulmann,et al. C-myc oncogene amplification in ductal carcinoma in situ of the breast , 2002, Breast Cancer Research and Treatment.
[15] J. Isola,et al. Amplification of c-myc Oncogene by Chromogenic and Fluorescence In Situ Hybridization in Archival Breast Cancer Tissue Array Samples , 2001, Laboratory Investigation.
[16] Daniel J Schaid,et al. ERBB2, TBX2, RPS6KB1, and MYC alterations in breast tissues of BRCA1 and BRCA2 mutation carriers , 2004, Genes, chromosomes & cancer.
[17] M. J. van de Vijver,et al. Association of C‐MYC amplification with progression from the in situ to the invasive stage in C‐MYC‐amplified breast carcinomas , 2003, The Journal of pathology.
[18] R. Dickson,et al. Overexpression of c-Myc Alters G1/S Arrest following Ionizing Radiation , 2002, Molecular and Cellular Biology.
[19] Rodrigo Arriagada,et al. Prognostic factors for death after an isolated local recurrence in patients with early‐stage breast carcinoma , 2002, Cancer.
[20] A. Magener,et al. Extensive and predominant in situ component in breast carcinoma: their influence on treatment results after breast-conserving therapy. , 1998, European Journal of Cancer.
[21] F. Orr,et al. C‐myc gene expression alone is sufficient to confer resistance to antiestrogen in human breast cancer cells , 2002, International journal of cancer.
[22] N. Lee,et al. Identification of c-myc responsive genes using rat cDNA microarray. , 2000, Cancer research.
[23] R. Simmons,et al. Locally recurrent breast cancer after conservation therapy. , 2005, American journal of surgery.
[24] D. Rimm,et al. Molecular markers for prognosis after isolated postmastectomy chest wall recurrence , 2004, Cancer.
[25] Norhanom Abdul Wahab,et al. Protein expression and molecular analysis of c-myc gene in primary breast carcinomas using immunohistochemistry and differential polymerase chain reaction. , 2002, International journal of molecular medicine.
[26] R. Dickson,et al. Dual regulation of proliferation and apoptosis: c-myc in bitransgenic murine mammary tumor models , 2000, Oncogene.
[27] P. Regitnig,et al. Microsatellite analysis of breast carcinoma and corresponding local recurrences , 2002, The Journal of pathology.
[28] R. Cardiff,et al. Transgenic oncogene mice. Tumor phenotype predicts genotype. , 1991, The American journal of pathology.
[29] L. Holmberg,et al. Risk factors for local recurrence after breast‐conserving surgery , 2003, The British journal of surgery.
[30] J. Coebergh,et al. Local recurrence after breast conservation therapy for early stage breast carcinoma: detection, treatment, and outcome in 266 patients. Dutch Study Group on Local Recurrence after Breast Conservation (BORST). , 1999, Cancer.
[31] B. Dutrillaux,et al. Gene amplifications detected by fluorescence in situ hybridization in pure intraductal breast carcinomas: Relation to morphology, cell proliferation and expression of breast cancer‐related genes , 2000, International journal of cancer.
[32] Peter Schraml,et al. Prognostic Relevance of Gene Amplifications and Coamplifications in Breast Cancer , 2004, Cancer Research.
[33] W. Remmele,et al. Relation of elastosis to biochemical and immunohistochemical steroid receptor findings, Ki-67 and epidermal growth factor receptor (EGFR) immunostaining in invasive ductal breast cancer , 2005, Virchows Archiv A.
[34] P. Lichter,et al. Variable breakpoints in Burkitt lymphoma cells with chromosomal t(8;14) translocation separate c-myc and the IgH locus up to several hundred kb. , 1992, Human molecular genetics.
[35] T. Ried,et al. Myc/p53 interactions in transgenic mouse mammary development, tumorigenesis and chromosomal instability , 1998, Oncogene.